Commerce Bank’s Mural Oncology MURA Stock Holding History

Commerce Bank’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,780	Closed	-$17.4K	–	1204
2025 Q1	$17.4K	Hold	13,780	–	–	﹤0.01%	1170
2024 Q4	$44.4K	Buy	13,780 +1,357	+11%	+$4.78K	﹤0.01%	1174
2024 Q3	$38.9K	Buy	+12,423	New	+$40.5K	﹤0.01%	1214

Other funds holding MURA

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commerce Bank's MURA Position: Q2 2025 in Review

Commerce Bank sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 13,780 shares — an estimated $17.4K sold.

Commerce Bank first reported a position in MURA in Q3 2024 and held it in 3 quarters. The position peaked at $44.4K in Q4 2024. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

Commerce Bank reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
Commerce Bank sold 13,780 Mural Oncology shares in Q2 2025, an estimated $17.4K.
Commerce Bank first reported a position in Mural Oncology in Q3 2024 and held it in 3 quarters.
Commerce Bank's Mural Oncology position peaked at $44.4K in Q4 2024.
66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Commerce Bank's 13F filing for Q2 2025, filed 7 Aug 2025.